Back to today’s briefing

Story perspectives

Gene Therapy Faces Funding and Safety Hurdles for Rare Disorders

3/2/2025

24 5

Summary

Story summary

Experts shed light on the hurdles facing gene therapies for rare genetic disorders known as inborn errors of metabolism. Key challenges include securing funding, navigating reimbursement issues, and addressing safety concerns for vulnerable newborns. While current treatments rely on dietary restrictions, the promise of gene therapies to reverse disease progression faces resistance from established alternatives.

1 of 1

Story summary

Experts shed light on the hurdles facing gene therapies for rare genetic disorders known as inborn errors of metabolism. Key challenges include securing funding, navigating reimbursement issues, and addressing safety concerns for vulnerable newborns. While current treatments rely on dietary restrictions, the promise of gene therapies to reverse disease progression faces resistance from established alternatives.